Rachel A. Brown

1.1k total citations
26 papers, 856 citations indexed

About

Rachel A. Brown is a scholar working on Immunology, Hematology and Small Animals. According to data from OpenAlex, Rachel A. Brown has authored 26 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Hematology and 4 papers in Small Animals. Recurrent topics in Rachel A. Brown's work include Autoimmune and Inflammatory Disorders Research (4 papers), Adenosine and Purinergic Signaling (3 papers) and T-cell and Retrovirus Studies (2 papers). Rachel A. Brown is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (4 papers), Adenosine and Purinergic Signaling (3 papers) and T-cell and Retrovirus Studies (2 papers). Rachel A. Brown collaborates with scholars based in United States, United Kingdom and Czechia. Rachel A. Brown's co-authors include Clive Page, Domenico Spina, Seth L. Blumerman, Cynthia L. Baldwin, Brian Naiman, Rebecca Lever, Shima Yasin, Neil A. Jones, Alexei A. Grom and Grant S. Schulert and has published in prestigious journals such as JAMA, Environmental Health Perspectives and Journal of the American Society of Nephrology.

In The Last Decade

Rachel A. Brown

25 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel A. Brown United States 15 244 219 140 137 133 26 856
Melanie Scully United States 12 376 1.5× 387 1.8× 136 1.0× 171 1.2× 23 0.2× 14 1.1k
Christina J. Thomas Germany 6 571 2.3× 794 3.6× 118 0.8× 51 0.4× 56 0.4× 7 1.2k
JanWillem Duitman Netherlands 19 207 0.8× 304 1.4× 52 0.4× 83 0.6× 135 1.0× 57 1.1k
Alexandra dos Anjos Cassado Brazil 8 350 1.4× 198 0.9× 65 0.5× 58 0.4× 19 0.1× 9 724
Peter Georgiev United States 12 677 2.8× 350 1.6× 85 0.6× 57 0.4× 22 0.2× 28 1.2k
Vered Molho‐Pessach Israel 19 178 0.7× 270 1.2× 258 1.8× 91 0.7× 26 0.2× 57 1.1k
Sujata Srikanth United States 16 158 0.6× 225 1.0× 45 0.3× 11 0.1× 124 0.9× 35 851
Gerardo A. Mirkin Argentina 17 314 1.3× 313 1.4× 186 1.3× 17 0.1× 22 0.2× 30 1.2k
B. Ryffel Switzerland 19 517 2.1× 354 1.6× 121 0.9× 12 0.1× 41 0.3× 36 1.2k
Elisabeth M. Thornton United Kingdom 16 571 2.3× 268 1.2× 87 0.6× 12 0.1× 36 0.3× 22 988

Countries citing papers authored by Rachel A. Brown

Since Specialization
Citations

This map shows the geographic impact of Rachel A. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Brown more than expected).

Fields of papers citing papers by Rachel A. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Brown. The network helps show where Rachel A. Brown may publish in the future.

Co-authorship network of co-authors of Rachel A. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Brown. A scholar is included among the top collaborators of Rachel A. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Brown. Rachel A. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yasin, Shima, Ndate Fall, Rachel A. Brown, et al.. (2019). IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Lara D. Veeken. 59(2). 361–366. 82 indexed citations
3.
Brown, Rachel A., Thuy Do, Shima Yasin, et al.. (2018). Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease. Frontiers in Immunology. 9. 2995–2995. 48 indexed citations
4.
Malkar, Manish B., Stephen E. Welty, Rachel A. Brown, et al.. (2012). Tracheostomy placement in infants with bronchopulmonary dysplasia: Safety and outcomes. Pediatric Pulmonology. 48(3). 245–249. 52 indexed citations
5.
Brown, Rachel A., Euphemia Leung, Hannu Kankaanranta, Eeva Moilanen, & Clive Page. (2012). Effects of heparin and related drugs on neutrophil function. Pulmonary Pharmacology & Therapeutics. 25(2). 185–192. 17 indexed citations
6.
Brown, Rachel A., et al.. (2011). Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis. Clinical Rheumatology. 31(3). 455–461. 32 indexed citations
7.
Wilson, Constance N., Ahmed Nadeem, Domenico Spina, et al.. (2009). Adenosine Receptors and Asthma. Handbook of experimental pharmacology. 329–362. 67 indexed citations
8.
Brown, Rachel A., Domenico Spina, & Clive Page. (2008). Adenosine receptors and asthma. British Journal of Pharmacology. 153(S1). S446–56. 110 indexed citations
9.
Brown, Rachel A., Graham W. Clarke, Jane Denyer, et al.. (2007). Elevated expression of adenosine A1receptor in bronchial biopsy specimens from asthmatic subjects. European Respiratory Journal. 31(2). 311–319. 44 indexed citations
10.
Brown, Rachel A., L. Allegra, Maria Gabriella Matera, Clive Page, & Mario Cazzola. (2006). Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulmonary Pharmacology & Therapeutics. 19(6). 419–424. 26 indexed citations
11.
Brown, Victoria, Rachel A. Brown, Adrian Ozinsky, Jay R. Hesselberth, & Stanley Fields. (2006). Binding specificity of Toll‐like receptor cytoplasmic domains. European Journal of Immunology. 36(3). 742–753. 54 indexed citations
12.
Brown, Rachel A., et al.. (2004). Widespread Kaposi's Sarcoma in an HIV‐Negative Man. SKINmed Dermatology for the Clinician. 3(2). 108–109. 1 indexed citations
13.
Brown, Rachel A., Rebecca Lever, Neil A. Jones, & Clive Page. (2003). Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. British Journal of Pharmacology. 139(4). 845–853. 59 indexed citations
14.
Naiman, Brian, Seth L. Blumerman, David P. Alt, et al.. (2002). Evaluation of Type 1 Immune Response in Naive and Vaccinated Animals following Challenge withLeptospira borgpeterseniiSerovar Hardjo: Involvement of WC1+γδ and CD4 T Cells. Infection and Immunity. 70(11). 6147–6157. 80 indexed citations
15.
Baldwin, Cynthia L., Brian Naiman, Rachel A. Brown, et al.. (2002). Activation of bovine peripheral blood γδ T cells for cell division and IFN-γ production. Veterinary Immunology and Immunopathology. 87(3-4). 251–259. 42 indexed citations
16.
Fonseca, V, et al.. (1986). Acute adrenal crisis precipitated by thyroxine.. BMJ. 292(6529). 1185–1186. 33 indexed citations
17.
Kaneene, John B., et al.. (1980). Studies on In Vitro Lymphocyte Stimulation Assay in Cattle Naturally Infected with Brucella abortus and in Cattle Vaccinated with Strain 19. American Journal of Veterinary Research. 41(10). 1586–1589. 3 indexed citations
18.
Calabrese, Edward J., et al.. (1979). Effects of environmental oxidant stressors on individuals with a G-6-PD deficiency with particular reference to an animal model.. Environmental Health Perspectives. 29. 49–55. 8 indexed citations
19.
Brown, Rachel A. & G.B. West. (1965). The Antihistaminic Activity of Lysozyme. International Archives of Allergy and Immunology. 26(4). 204–214. 3 indexed citations
20.
Brown, Rachel A., et al.. (1953). The Assay for the Histamine-like Activity of Some Antibiotics. Journal of the American Pharmaceutical Association (Scientific ed ). 42(4). 257–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Scully Breakdown of academic impact, for papers by Christina J. Thomas Breakdown of academic impact, for papers by JanWillem Duitman Breakdown of academic impact, for papers by Alexandra dos Anjos Cassado Breakdown of academic impact, for papers by Peter Georgiev Breakdown of academic impact, for papers by Vered Molho‐Pessach Breakdown of academic impact, for papers by Sujata Srikanth Breakdown of academic impact, for papers by Gerardo A. Mirkin Breakdown of academic impact, for papers by B. Ryffel Breakdown of academic impact, for papers by Elisabeth M. Thornton
Rankless by CCL
2026